US 10144726
Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer
granted A61KA61K31/498A61K31/53
Quick answer
US patent 10144726 (Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer) held by SENTINEL ONCOLOGY LIMITED expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTINEL ONCOLOGY LIMITED
- Grant date
- Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/498, A61K31/53, A61P, A61P35/04